ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,848.10
-0.05%
S&P ASX All Technology
3,074.90
-0.10%
Brent Oil
81.83
-0.75%
US Dollar vs AUD
1.50132
0.09%
Bitcoin
69,831.95
-0.43%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Organovo Holdings Inc (ONVO)

  7. Organovo Holdings Inc (ONVO) News

ONVO

Organovo (ONVO)

Organovo Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ONVO
DateTimeSourceHeadlineSymbolCompany
21/05/202422:05GlobeNewswire Inc.Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Combination Therapy with Tofacitinib for Inflammatory Bowel DiseaseNASDAQ:ONVOOrganovo Holdings Inc
15/05/202402:45Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ONVOOrganovo Holdings Inc
15/05/202401:00GlobeNewswire Inc.Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024)NASDAQ:ONVOOrganovo Holdings Inc
14/05/202407:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONVOOrganovo Holdings Inc
11/05/202407:15Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ONVOOrganovo Holdings Inc
09/05/202410:00GlobeNewswire Inc.Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public OfferingNASDAQ:ONVOOrganovo Holdings Inc
15/04/202422:05GlobeNewswire Inc.Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to PlaceboNASDAQ:ONVOOrganovo Holdings Inc
09/02/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ONVOOrganovo Holdings Inc
09/02/202408:56Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ONVOOrganovo Holdings Inc
09/02/202408:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ONVOOrganovo Holdings Inc
08/02/202400:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONVOOrganovo Holdings Inc
27/01/202409:09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ONVOOrganovo Holdings Inc
26/01/202400:05GlobeNewswire Inc.Organovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn’s and Colitis CongressNASDAQ:ONVOOrganovo Holdings Inc
10/01/202400:05GlobeNewswire Inc.Organovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn’s and Colitis CongressNASDAQ:ONVOOrganovo Holdings Inc
29/12/202308:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONVOOrganovo Holdings Inc
22/12/202322:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ONVOOrganovo Holdings Inc
07/12/202300:05GlobeNewswire Inc.Organovo Provides Timing for Release of FXR314 Phase 2 NASH ResultsNASDAQ:ONVOOrganovo Holdings Inc
02/12/202308:07Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ONVOOrganovo Holdings Inc
18/11/202310:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONVOOrganovo Holdings Inc
18/11/202310:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONVOOrganovo Holdings Inc
18/11/202310:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONVOOrganovo Holdings Inc
18/11/202310:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONVOOrganovo Holdings Inc
18/11/202310:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONVOOrganovo Holdings Inc
16/11/202308:41Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ONVOOrganovo Holdings Inc
14/11/202300:05GlobeNewswire Inc.CORRECTION – Organovo Highlights FXR314 Combination Therapy Potential and PlanNASDAQ:ONVOOrganovo Holdings Inc
10/11/202309:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ONVOOrganovo Holdings Inc
09/11/202300:05GlobeNewswire Inc.Organovo Highlights FXR314 Combination Therapy Potential and PlanNASDAQ:ONVOOrganovo Holdings Inc
03/11/202323:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONVOOrganovo Holdings Inc
23/09/202306:05Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ONVOOrganovo Holdings Inc
14/09/202307:07Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ONVOOrganovo Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:ONVO

Your Recent History

NYSE
JPM
JP Morgan Chase
ASX
WBC
Westpac Banking
ASX
TLS
Telstra
ASX
ORG
Origin Energy
ASX
ANZ
Australia And New Zealan...
PM
XAUUSD
Gold vs US Dollar
NYSE
VZ
Verizon Communications
FX
GBPAUD
Sterling vs AUD
ASX
WPL
Woodside Petroleum
ASX
XJO
S&P ASX 200
NASDAQ
GOOGL
Alphabet
ASX
XMM
S&P ASX 300 Metals and M...
NYSE
MRK
Merck
ASX
NCM
Newcrest Mining
NASDAQ
QQQ
Invesco QQQ Trust Series 1
COIN
ETHUSD
Ethereum
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved